<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10402173" created="02/07/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10402173</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Suppression of <term id="T1" lex="NF-kappaB_activation" sem="Other"><term id="T2" lex="NF-kappaB" sem="Protein_molecule">NF-kappaB</term> activation</term> in <term id="T3" lex="normal_T_cell" sem="Cell_natural">normal T cells</term> by <term id="T4" lex="supernatant_fluid" sem="Other">supernatant fluid</term> from <term id="T5" lex="human_renal_cell_carcinoma" sem="Other">human renal cell carcinomas</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T4" idref1="T5"/>
<clue><clueType>Suppression</clueType> <linkTheme>of</linkTheme> NF-kappaB activation in normal T cells <linkCause>by</linkCause> supernatant fluid from human renal cell carcinomas.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<clue>Suppression of NF-kappaB <clueType>activation</clueType> <clueLoc>in normal T cells</clueLoc> by supernatant fluid from human renal cell carcinomas.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> from patients with <term id="T7" lex="renal_cell_carcinoma" sem="Other">renal cell carcinoma</term> (<term id="T8" lex="RCC" sem="Other">RCC</term>) show reduced <term id="T9" lex="immune_function" sem="Other">immune function</term> and impaired activation of the <term id="T10" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term>, <term id="T11" lex="NF-kappaB" sem="Protein_molecule">NF-kappaB</term>.</sentence>
<event KT="Analysis" id="E3">
<type class="Negative_regulation"/>
<theme idref="E4"/>
<clue><clueLoc>T lymphocytes from patients with renal cell carcinoma (RCC)</clueLoc> <clueKT>show</clueKT> <clueType>reduced</clueType> immune function and impaired activation of the transcription factor, NF-kappaB.</clue>
</event>
<event KT="Other" id="E4">
<type class="Physiological_process"/>
<theme idref="T6"/>
<clue>T lymphocytes from patients with renal cell carcinoma (RCC) show reduced <clueType>immune function</clueType> and impaired activation of the transcription factor, NF-kappaB.</clue>
</event>
<event KT="Analysis" id="E5">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<clue><clueLoc>T lymphocytes from patients with renal cell carcinoma (RCC)</clueLoc> <clueKT>show</clueKT> reduced immune function and <clueType>impaired</clueType> activation of the transcription factor, NF-kappaB.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<clue>T lymphocytes from patients with renal cell carcinoma (RCC) show reduced immune function and impaired <clueType>activation</clueType> <linkTheme>of</linkTheme> the transcription factor, NF-kappaB.</clue>
</event>
<sentence id="S3">We determined the mechanism of <term id="T12" lex="NF-kappaB_suppression" sem="Other"><term id="T13" lex="NF-kappaB" sem="Protein_molecule">NF-kappaB</term> suppression</term> in <term id="T14" lex="T_cell" sem="Cell_natural">T cells</term> of <term id="T15" lex="RCC_patient" sem="Multicellular_organism_natural"><term id="T16" lex="RCC" sem="Other">RCC</term> patient</term> and determined whether supernatant fluid from <term id="T17" lex="RCC" sem="Other">RCC</term> explants (<term id="A1" sem="Other"><term id="T18" lex="RCC" sem="Other">RCC</term>-S</term>) induced the same phenotype of <term id="T19" lex="NF-kappaB_suppression" sem="Other"><term id="T20" lex="NF-kappaB" sem="Protein_molecule">NF-kappaB</term> suppression</term> in <term id="T21" lex="normal_T_cell" sem="Cell_natural">normal <term id="T22" lex="T_cell" sem="Cell_natural">T cells</term></term> that is observed in patient <term id="T23" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event KT="Analysis" id="E7" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T13"/>
<clue>We <clueKT>determined</clueKT> the mechanism of NF-kappaB <clueType>suppression</clueType> <clueLoc>in T cells of RCC patient</clueLoc> and determined whether supernatant fluid from RCC explants (RCC-S) induced the same phenotype of NF-kappaB suppression in normal T cells that is observed in patient T cells.</clue>
</event>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T20"/>
<cause idref="A1"/>
<clue>We determined the mechanism of NF-kappaB suppression in T cells of RCC patient and <clueKT>determined whether</clueKT> supernatant fluid from RCC explants (RCC-S) <clueType>induced</clueType> the same phenotype of NF-kappaB <clueType>suppression</clueType> <clueLoc>in normal T cells</clueLoc> that is observed in patient T cells.</clue>
</event>
<sentence id="S4">The pattern of <term id="T24" lex="kappaB-binding_activity" sem="Other"><term id="T25" lex="kappaB" sem="Protein_molecule">kappaB</term>-binding activity</term> in <term id="T26" lex="T_cell" sem="Cell_natural">T cells</term> of <term id="T27" lex="RCC" sem="Other">RCC</term> patient was altered as compared to that seen in <term id="T28" lex="T_cell" sem="Cell_natural">T cells</term> obtained from normal volunteers.</sentence>
<event id="E9">
<type class="Binding"/>
<theme idref="T25"/>
<clue>The pattern of kappaB-<clueType>binding activity</clueType> <clueLoc>in T cells of RCC patient</clueLoc> was altered as compared to that seen in T cells obtained from normal volunteers.</clue>
</event>
<event id="E32">
<type class="Binding"/>
<theme idref="T25"/>
<clue>The pattern of kappaB-<clueType>binding activity</clueType> in T cells of RCC patient was altered as compared to that <clueKT>seen</clueKT> <clueLoc>in T cells obtained from normal volunteers</clueLoc>.</clue>
</event>
<event assertion="non-exist" id="E10">
<type class="Correlation"/>
<theme idref="E9"/>
<theme idref="E32"/>
<clue>The pattern of kappaB-binding activity in T cells of RCC patient was <clueType>altered</clueType> as compared to that seen in T cells obtained from normal volunteers.</clue>
</event>
<sentence id="S5">In some patients, no activation of <term id="T29" lex="RelA/NFkappaB1-binding_activity" sem="Other"><term id="T30" lex="RelA/NFkappaB1" sem="Protein_complex"><term id="A4" sem="Protein_molecule">RelA</term>/<term id="A5" sem="Protein_molecule">NFkappaB1</term></term>-binding activity</term> was detectable, while in others <term id="T31" lex="kappaB-binding_activity" sem="Other"><term id="T32" lex="kappaB" sem="Protein_molecule">kappaB</term>-binding activity</term> was modestly induced but the duration was reduced.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E11">
<type class="Positive_regulation"/>
<theme idref="E33"/>
<clue><clueLoc>In some patients</clueLoc>, <cluePolarity>no</cluePolarity> <clueType>activation</clueType> <linkTheme>of</linkTheme> RelA/NFkappaB1-binding activity was <clueKT>detectable</clueKT>, while in others kappaB-binding activity was modestly induced but the duration was reduced.</clue>
</event>
<event KT="Other" id="E33">
<type class="Binding"/>
<theme idref="A4"/>
<theme idref="A5"/>
<clue>In some patients, no activation of RelA/NFkappaB1-<clueType>binding</clueType> activity was detectable, while in others kappaB-binding activity was modestly induced but the duration was reduced.</clue>
</event>
<event id="E12">
<type class="Binding"/>
<theme idref="T32"/>
<clue>In some patients, no activation of RelA/NFkappaB1-binding activity was detectable, while in others kappaB-<clueType>binding activity</clueType> was modestly induced but the duration was reduced.</clue>
</event>
<event Manner="Low" id="E13">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<clue>In some patients, no activation of RelA/NFkappaB1-binding activity was detectable, while in others kappaB-binding activity was<clueManner> modestly</clueManner> <clueType>induced</clueType> but the duration was reduced.</clue>
</event>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<clue>In some patients, no activation of RelA/NFkappaB1-binding activity was detectable, while in others kappaB-binding activity was modestly induced but the <clueType>duration</clueType> was <clueType>reduced</clueType>.</clue>
</event>
<sentence id="S6"><term id="T33" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> was degraded normally following stimulation in both <term id="A3" sem="Cell_natural">normal controls</term> and <term id="T34" lex="T_cell" sem="Cell_natural">T cells</term> from <term id="T35" lex="RCC_patient" sem="Multicellular_organism_natural"><term id="T36" lex="RCC" sem="Other">RCC</term> patients</term>.</sentence>
<event KT="Other" id="E15">
<type class="Protein_catabolism"/>
<theme idref="T33"/>
<clue>IkappaBalpha was <clueType>degraded</clueType> normally following stimulation <clueLoc>in</clueLoc> both <clueLoc>normal controls</clueLoc> and T cells from RCC patients.</clue>
</event>
<event KT="Other" id="E16">
<type class="Protein_catabolism"/>
<theme idref="T33"/>
<clue>IkappaBalpha was <clueType>degraded</clueType> normally following stimulation <clueLoc>in</clueLoc> both normal controls and <clueLoc>T cells from RCC patients</clueLoc>.</clue>
</event>
<event KT="Analysis" id="E34">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E17"/>
<clue>IkappaBalpha was degraded <clueKT>normally</clueKT> <linkCause>following</linkCause> stimulation in both normal controls and T cells from RCC patients.</clue>
</event>
<event KT="Analysis" id="E35">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="E18"/>
<clue>IkappaBalpha was degraded <clueKT>normally</clueKT> <linkCause>following</linkCause> stimulation in both normal controls and T cells from RCC patients.</clue>
</event>
<event KT="Other" id="E17">
<type class="Physiological_process"/>
<theme idref="A3"/>
<clue>IkappaBalpha was degraded normally following <clueType>stimulation</clueType> <linkTheme>in</linkTheme> both normal controls and T cells from RCC patients.</clue>
</event>
<event KT="Other" id="E18">
<type class="Physiological_process"/>
<theme idref="T34" idref1="T36"/>
<clue>IkappaBalpha was degraded normally following <clueType>stimulation</clueType> <linkTheme>in</linkTheme> both normal controls and T cells from RCC patients.</clue>
</event>
<sentence id="S7"><term id="T37" lex="RCC-S" sem="Other"><term id="T38" lex="RCC" sem="Other">RCC</term>-S</term> did not alter the cytoplasmic levels of <term id="T39" lex="RelA" sem="Protein_molecule">RelA</term> and <term id="T40" lex="NF-kappaB1" sem="Protein_molecule">NF-kappaB1</term> but did suppress their <term id="T41" lex="nuclear_localization" sem="Other">nuclear localization</term> and inhibited the activation of <term id="T42" lex="RelA/NF-kappaB1_binding_complex" sem="Protein_complex"><term id="T43" lex="RelA" sem="Protein_molecule">RelA</term><term id="T44" lex="NF-kappaB1" sem="Protein_molecule">/NF-kappaB1</term> binding complexes</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E19">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T37"/>
<clue>RCC-S did <cluePolarity>not</cluePolarity> <clueType>alter</clueType> the <clueLoc>cytoplasmic</clueLoc> <clueType>levels</clueType> <linkTheme>of</linkTheme> RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E20">
<type class="Regulation"/>
<theme idref="T40"/>
<cause idref="T37"/>
<clue>RCC-S did <cluePolarity>not</cluePolarity> <clueType>alter</clueType> the <clueLoc>cytoplasmic</clueLoc> <clueType>levels</clueType> <linkTheme>of</linkTheme> RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.</clue>
</event>
<event id="E21">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T37"/>
<clue>RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did <clueType>suppress</clueType> their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="T37"/>
<clue>RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did <clueType>suppress</clueType> their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.</clue>
</event>
<event KT="Other" id="E23">
<type class="Localization"/>
<theme idref="T39"/>
<clue>RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress <corefTheme>their</corefTheme> <clueLoc>nuclear</clueLoc> <clueType>localization</clueType> and inhibited the activation of RelA/NF-kappaB1 binding complexes.</clue>
</event>
<event KT="Other" id="E24">
<type class="Localization"/>
<theme idref="T40"/>
<clue>RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress <corefTheme>their</corefTheme> <clueLoc>nuclear</clueLoc> <clueType>localization</clueType> and inhibited the activation of RelA/NF-kappaB1 binding complexes.</clue>
</event>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T37"/>
<clue>RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and <clueType>inhibited</clueType> the activation of RelA/NF-kappaB1 binding complexes.</clue>
</event>
<event KT="Other" id="E26">
<type class="Positive_regulation"/>
<theme idref="T42"/>
<clue>RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the <clueType>activation</clueType> <linkTheme>of</linkTheme> RelA/NF-kappaB1 binding complexes.</clue>
</event>
<sentence id="S8">These results show that <term id="A2" sem="Other"><term id="T45" lex="RCC" sem="Other">RCC</term>-S</term> can induce in <term id="T46" lex="normal_T_cell" sem="Cell_natural">normal <term id="T47" lex="T_cell" sem="Cell_natural">T cells</term></term> the same phenotype of impaired <term id="T48" lex="NF-kappaB_activation" sem="Other"><term id="T49" lex="NF-kappaB" sem="Protein_molecule">NF-kappaB</term> activation</term> that is detected in <term id="T50" lex="T_cell" sem="Cell_natural">T cells</term> of <term id="T51" lex="RCC" sem="Other">RCC</term> patient.</sentence>
<event CL="L2" KT="Analysis" id="E27">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="A2"/>
<clue>These results <clueKT>show</clueKT> that RCC-S <clueCL>can</clueCL> <clueType>induce</clueType> <clueLoc>in normal T cells</clueLoc> the same phenotype of impaired NF-kappaB activation that is detected in T cells of RCC patient.</clue>
</event>
<event KT="Other" assertion="non-exist" id="E28">
<type class="Positive_regulation"/>
<theme idref="T49"/>
<clue>These results show that RCC-S can induce in normal T cells the same phenotype of <clueType>impaired</clueType> NF-kappaB <clueType>activation</clueType> that is detected in T cells of RCC patient.</clue>
</event>
<event assertion="non-exist" id="E29">
<type class="Positive_regulation"/>
<theme idref="T49"/>
<clue>These results show that RCC-S can induce in normal T cells the same phenotype of <clueType>impaired</clueType> NF-kappaB <clueType>activation</clueType> that is <clueKT>detected</clueKT> <clueLoc>in T cells of RCC patient</clueLoc>.</clue>
<comment>CAUTION: SEE</comment></event>
<sentence id="S9">It also appears that <term id="T52" lex="NF-kappaB_suppression" sem="Other"><term id="T53" lex="NF-kappaB" sem="Protein_molecule">NF-kappaB</term> suppression</term> by <term id="T54" lex="RCC-S" sem="Other"><term id="T55" lex="RCC" sem="Other">RCC</term>-S</term> may contribute to the <term id="T56" lex="immunosuppression" sem="Other">immunosuppression</term> of <term id="T57" lex="host_immunity" sem="Other">host immunity</term>.</sentence>
<event KT="Other" id="E30">
<type class="Negative_regulation"/>
<theme idref="T53"/>
<cause idref="T54"/>
<clue>It also appears that NF-kappaB <clueType>suppression</clueType> <linkCause>by</linkCause> RCC-S may contribute to the immunosuppression of host immunity.</clue>
</event>
<event CL="L1" KT="Analysis" id="E31" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T56"/>
<cause idref="E30"/>
<clue>It also <clueKT>appears</clueKT> that NF-kappaB suppression by RCC-S <clueCL>may</clueCL> <clueType>contribute</clueType> <linkTheme>to</linkTheme> the immunosuppression of host immunity.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
